The breast ultrasound market is expected to grow at a CAGR of 8.3% during 2026–2034, driven by the rising prevalence of breast cancer, increasing awareness of early detection, and growing use of supplemental imaging for women with dense breast tissue. Breast ultrasound is widely used as a non-ionizing diagnostic imaging tool for lesion characterization, dense breast evaluation, biopsy guidance, and follow-up examinations. Market growth is also supported by technological advancements in automated breast ultrasound systems that improve workflow efficiency and diagnostic consistency. Healthcare providers are increasingly integrating breast ultrasound into routine breast imaging pathways, especially as healthcare systems emphasize early cancer detection and improved patient outcomes.
Market Drivers
Market growth is driven by increasing global breast cancer incidence and the growing importance of early screening and diagnosis. Mammography remains the primary screening tool, but breast ultrasound is increasingly used as a complementary imaging technique, particularly for women with dense breast tissue where mammography may have limitations. Technological advancements in ultrasound imaging, including high-resolution probes, elastography, and automated breast ultrasound systems (ABUS), are improving diagnostic accuracy and workflow efficiency. Rising investments in healthcare infrastructure, expanding imaging capabilities in developing regions, and growing awareness of women’s health are further supporting market expansion. In addition, hospitals and diagnostic centers are adopting advanced imaging solutions to enhance patient throughput and improve diagnostic outcomes.
Market Restraints
The market faces restraints due to the operator-dependent nature of conventional ultrasound, which can result in variability in imaging quality and interpretation. Automated systems can reduce variability but require higher initial capital investment and specialized training for clinical staff. False-positive findings and higher recall rates in supplemental screening can also increase follow-up procedures and healthcare costs. In addition, competition from other advanced imaging modalities such as MRI and contrast-enhanced mammography may limit adoption in certain high-resource healthcare settings. Budget constraints in developing healthcare systems can also restrict the adoption of advanced automated ultrasound technologies.
Market Segmentation
By Type
By type, the market is segmented into conventional ultrasound and automated ultrasound. Conventional ultrasound holds a major share due to its widespread availability, lower cost, and routine use in diagnostic imaging and biopsy guidance. It remains a standard tool for evaluating suspicious breast lesions and conducting targeted scans. Automated ultrasound is the fastest-growing segment because it offers standardized imaging, improved reproducibility, and enhanced workflow efficiency. Automated breast ultrasound systems are particularly useful for screening women with dense breast tissue and provide three-dimensional imaging for more consistent evaluation.
By End Use
By end use, the market is segmented into hospitals, diagnostic laboratories, and other end users. Hospitals dominate the market due to the availability of advanced imaging infrastructure, specialized radiology departments, and high patient volumes requiring diagnostic imaging and biopsy procedures. Diagnostic laboratories and imaging centers also represent a significant segment, as they provide outpatient diagnostic imaging services and faster appointment availability for screening and follow-up imaging. Other end users include specialized clinics and ambulatory care centers that increasingly offer breast imaging services as part of comprehensive women’s healthcare.
Regional Insights
North America represents a major market due to strong awareness of breast cancer screening, high healthcare spending, and widespread availability of advanced diagnostic imaging technologies. Europe also holds a significant share supported by organized screening programs, strong healthcare infrastructure, and increasing adoption of advanced imaging technologies. Asia Pacific is expected to be the fastest-growing region due to expanding healthcare infrastructure, rising awareness of breast health, and increasing investments in diagnostic imaging technologies across countries such as China, India, Japan, and South Korea. Latin America and the Middle East & Africa are expected to experience moderate growth as healthcare systems expand access to diagnostic imaging and improve cancer detection capabilities.
Competitive Landscape
The breast ultrasound market is highly competitive and technology-driven, with companies focusing on improving imaging quality, automation capabilities, workflow efficiency, and integration with broader breast imaging solutions. Manufacturers are investing in advanced imaging technologies, artificial intelligence-based image analysis, and automated scanning systems to improve diagnostic accuracy and reduce operator dependency. Partnerships between equipment manufacturers, healthcare providers, and research institutions are supporting the development of next-generation imaging platforms. Vendors are also expanding their global presence through strategic collaborations, product innovation, and investments in emerging healthcare markets. Key companies operating in the market include CapeRay, Delphinus Medical Technologies, Inc., GE Healthcare, Koninklijke Philips N.V., Siemens Healthineers AG, Canon Medical Systems Corporation, Fukuda Denshi, Hologic, Inc., Seno Medical Instruments Inc., Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Samsung Electronics Co. Ltd., and FujiFilm Holdings Corporation.
Historical & Forecast Period
This study report represents analysis of each segment from 2024 to 2034 considering 2025 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2026 to 2034.
The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.
Research Methodology
The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Breast Ultrasound market are as follows:
Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.
| ATTRIBUTE | DETAILS |
|---|---|
| Research Period | 2024-2034 |
| Base Year | 2025 |
| Forecast Period | 2026-2034 |
| Historical Year | 2024 |
| Unit | USD Million |
| Segmentation | |
Type
|
|
End Use
|
|
|
Region Segment (2024-2034; US$ Million)
|
Frequently Asked Questions
What is the growth outlook for the breast ultrasound market?
The market is expected to grow at a CAGR of 8.3% during 2026–2034, driven by increasing breast cancer screening awareness and technological advancements in imaging systems.
Which type dominates the market today?
Conventional ultrasound dominates due to its wide availability, lower cost, and routine use in diagnostic imaging and biopsy guidance.
Which type is growing the fastest?
Automated ultrasound is growing the fastest because it provides standardized imaging, improved reproducibility, and better workflow efficiency in breast cancer screening.
What are the major challenges in this market?
Key challenges include operator dependency in conventional ultrasound, higher cost of automated systems, potential false positives in screening, and competition from other advanced imaging technologies.
Who are the key players in the market?
Major players include GE Healthcare, Philips, Siemens Healthineers, Canon Medical Systems, Hologic, Samsung Electronics, Mindray, Fujifilm Holdings, Delphinus Medical Technologies, and Seno Medical Instruments.
